Income Statement Medacta Group SA
Equities
MOVE
CH0468525222
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.00 CHF | -1.26% | +1.29% | +3.19% |
Sep. 25 | Swiss Market Index Advances Ahead of SNB's Rate Decision Day | MT |
Sep. 25 | Medacta Group SA - Analyst/Investor Day |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Revenues | 311M | 302M | 363M | 437M | 511M | |||
Total Revenues | 311M | 302M | 363M | 437M | 511M | |||
Cost of Goods Sold, Total | 86.93M | 88.24M | 102M | 132M | 163M | |||
Gross Profit | 224M | 214M | 261M | 305M | 348M | |||
Selling General & Admin Expenses, Total | 174M | 155M | 183M | 220M | 252M | |||
R&D Expenses | 7.64M | 6.83M | 10.91M | 15.08M | 18.77M | |||
Other Operating Expenses | -627K | -697K | -1.14M | 505K | 90K | |||
Other Operating Expenses, Total | 181M | 161M | 193M | 236M | 271M | |||
Operating Income | 43.09M | 52.84M | 67.98M | 69.46M | 76.51M | |||
Interest Expense, Total | -3.36M | -3.04M | -3.44M | -3.66M | -6.83M | |||
Interest And Investment Income | 46K | 144K | 332K | 348K | 103K | |||
Net Interest Expenses | -3.31M | -2.9M | -3.11M | -3.32M | -6.73M | |||
Currency Exchange Gains (Loss) | -2.44M | -7.66M | 1.03M | -2.98M | -10.46M | |||
Other Non Operating Income (Expenses) | -226K | 1.05M | -1.25M | -381K | 1.47M | |||
EBT, Excl. Unusual Items | 37.11M | 43.33M | 64.66M | 62.78M | 60.79M | |||
Merger & Related Restructuring Charges | - | - | - | - | - | |||
Gain (Loss) On Sale Of Assets | -159K | -1.14M | -901K | - | - | |||
Asset Writedown | - | - | -397K | -517K | -791K | |||
Legal Settlements | -14.66M | 840K | -7.91M | -6.85M | -524K | |||
Other Unusual Items | -8.66M | -3.1M | - | -627K | -753K | |||
EBT, Incl. Unusual Items | 13.63M | 39.93M | 55.45M | 54.79M | 58.73M | |||
Income Tax Expense | 1.77M | 2.84M | 3.93M | 8.54M | 11.36M | |||
Earnings From Continuing Operations | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M | |||
Net Income to Company | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M | |||
Net Income - (IS) | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M | |||
Net Income to Common Incl Extra Items | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M | |||
Net Income to Common Excl. Extra Items | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M | |||
Per Share Items | ||||||||
Net EPS - Basic | 0.59 | 1.85 | 2.58 | 2.32 | 2.37 | |||
Basic EPS - Continuing Operations | 0.59 | 1.85 | 2.58 | 2.32 | 2.37 | |||
Basic Weighted Average Shares Outstanding | 20M | 20M | 20M | 19.98M | 19.95M | |||
Net EPS - Diluted | 0.59 | 1.85 | 2.58 | 2.31 | 2.37 | |||
Diluted EPS - Continuing Operations | 0.59 | 1.85 | 2.58 | 2.31 | 2.37 | |||
Diluted Weighted Average Shares Outstanding | 20M | 20M | 20M | 20M | 19.99M | |||
Normalized Basic EPS | 1.16 | 1.35 | 2.02 | 1.96 | 1.9 | |||
Normalized Diluted EPS | 1.16 | 1.35 | 2.02 | 1.96 | 1.9 | |||
Dividend Per Share | - | - | 0.52 | 0.55 | 0.59 | |||
Payout Ratio | - | - | - | 22.53 | 23.34 | |||
Supplemental Items | ||||||||
EBITDA | 69.49M | 81.95M | 98.72M | 107M | 120M | |||
EBITA | 46.28M | 56.15M | 71.12M | 72.68M | 79.72M | |||
EBIT | 43.09M | 52.84M | 67.98M | 69.46M | 76.51M | |||
EBITDAR | 69.6M | 82.08M | 98.89M | 107M | 120M | |||
Effective Tax Rate - (Ratio) | 13.01 | 7.11 | 7.09 | 15.59 | 19.35 | |||
Total Current Taxes | -1.89M | 7.18M | 8.5M | 7.7M | 7.38M | |||
Total Deferred Taxes | 3.67M | -4.34M | -4.57M | 844K | 3.98M | |||
Normalized Net Income | 23.19M | 27.08M | 40.41M | 39.24M | 38M | |||
Interest on Long-Term Debt | 340K | 345K | 324K | 496K | 1.2M | |||
Non-Cash Pension Expense | -1.21M | -1.35M | -1.43M | -1.71M | -2.82M | |||
Supplemental Operating Expense Items | ||||||||
Selling and Marketing Expenses | 127M | 110M | 133M | 160M | 187M | |||
General and Administrative Expenses | 46.51M | 45.21M | 50.94M | 60.62M | 65.8M | |||
Research And Development Expense From Footnotes | 7.64M | 6.83M | 11.31M | 16.22M | 20.32M | |||
Net Rental Expense, Total | 106K | 122K | 173K | 170K | 317K | |||
Imputed Operating Lease Interest Expense | 17.95K | 19.59K | 33.35K | 32.39K | 92.09K | |||
Imputed Operating Lease Depreciation | 88.05K | 102K | 140K | 138K | 225K | |||
Stock-Based Comp., Other (Total) | - | - | 468K | 1.15M | 2.31M | |||
Total Stock-Based Compensation | - | - | 468K | 1.15M | 2.31M |